Cintas (CTAS) EBT Margin (2009 - 2026)

Cintas (CTAS) posted EBT Margin of 22.32% for Q2 2026, little changed sequentially from 22.26% in Q1 2026, and up 75.0% YoY from 12.75% in Q2 2025.

Cintas (CTAS) EBT Margin (2009 - 2026) Analysis & Trends

Cintas has reported EBT Margin for 18 years, with the latest figure at 22.32% in Q2 2026.

Quarterly EBT Margin rose 75.0% year-over-year to 22.32% in Q2 2026, while the trailing twelve-month figure through May 2026 was 22.24% (up 34.0% YoY) and the FY2026 annual result came in at 22.24%, up 34.0% from the prior year.
EBT Margin steadied at 22.32% in Q2 2026 per CTAS's latest filing, from 22.26% in the prior quarter.
Over five years, EBT Margin peaked at 22.48% in Q1 2025 and troughed at 18.39% in Q2 2022.
A 5-year average of 20.76% and a median of 20.98% in 2024 frame the typical range for EBT Margin.
The widest YoY moves for EBT Margin: up 268 bps in 2022, down 58 bps in 2022.
Over 5 years, EBT Margin stood at 19.14% in 2022, then rose by 4 bps to 19.93% in 2023, then climbed by 11 bps to 22.08% in 2024, then rose by 2 bps to 22.45% in 2025, then retreated by 1 bps to 22.32% in 2026.
According to Business Quant data, EBT Margin over the past three periods registered 22.32%, 22.26%, and 22.45% for Q2 2026, Q1 2026, and Q4 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBT Margin (Qtr)
1	Cintas	81.69 Bn	81.40 Bn	1.48 Bn	22.32%
2	Relx	64.97 Bn	64.80 Bn	-	-
3	Copart	32.09 Bn	28.74 Bn	732.88 Mn	40.59%
4	Global Payments	24.80 Bn	19.40 Bn	2.03 Bn	3.14%
5	Rb Global	16.24 Bn	15.72 Bn	935.50 Mn	14.12%
6	Aramark	15.68 Bn	15.18 Bn	430.34 Mn	2.68%
7	UL Solutions	15.20 Bn	14.77 Bn	417.00 Mn	41.42%
8	Rentokil Initial	11.80 Bn	9.27 Bn	-	-
9	Dolby Laboratories	6.05 Bn	5.38 Bn	264.68 Mn	14.36%
10	Unifirst	5.23 Bn	5.06 Bn	234.73 Mn	3.85%

Download Data